Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -8,240
▼ 52% vs 2024
Profit
Caution€ -8,922
▼ 48% vs 2024
Debts
Normal€ 325,654
▲ 4% vs 2024
BioGenCell Europe SA from Waterloo, company number BE0678674356, closed financial year 2025 with a result of € -8,922 after tax. For that financial year BioGenCell Europe SA recorded a gross margin of € -8,240 and equity of € 61,045. Compared with financial year 2024, the result moved from € -6,021 to € -8,922. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.
What happened at BioGenCell Europe SA?
What happened at BioGenCell Europe SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 8,922. Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 8,206 loss in 2022 to € 8,922 loss in 2025.
A new publication or filing at BioGenCell Europe SA? We notify you, reason included.
Follow BioGenCell Europe SANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind BioGenCell Europe SA are Yael Porat, Marc Dechamps and BIOGENCELL LTD Entreprise Etrangère Entreprise Etrangère. The same people are also behind XMF, BIOXODES, INVESTSUD TECH and INVESTSUD INNOVATION.
Directors
According to the 2025 annual accounts
Yael Porat
Director
BIOGENCELL LTD Entreprise Etrangère Entreprise Etrangère
Director · represented by Porat Yael
Establishments
Establishment units
Physical locations of this company
Avenue Louis David 68
1410 Waterloo
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0678.674.356
- VAT number
- BE 0678.674.356
- Registered office
- Avenue Louis David 68, 1410 Waterloo
- Names & denominations
- BioGenCell Europe SA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 July 2017
- Peppol
- Active · Active since 24 Mar 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied